Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Oct. 22, 2020 (GLOBE NEWSWIRE) -- The "Global Neurodegenerative Disorder Therapeutics Market: Focus on Product, Mechanism, Route of Administration, Indication, Country Data (14 Countries),...
-
TECFIDERA consistently maintained low levels of disease activity with no increased risk in adverse events over a decade of treatmentLatest interim data from Phase 3 EVOLVE-MS-1 trial show Biogen and...